Therapeutics for Equine Protozoal Myeloencephalitis.

The research article discusses the treatment for Equine Protozoal Myeloencephalitis (EPM), a central nervous system infection in horses caused by either Sarcocystis neurona or Neospora hughesi.

Research objectives

• The primary objective of this research is to investigate treatment strategies for Equine Protozoal Myeloencephalitis (EPM), an infectious disease that affects horses’ central nervous system. It also aims at shedding light on the diagnosis and prevention methods of the disease.

Methodology and approach

• The research uses careful analysis and interpretation of recent data related to diagnosis, treatment, and prevention of EPM. It offers insights into the use of FDA-approved anticoccidial drugs and the supportive medical procedures based on the severity of neurological deficits and other complications.

Understanding Equine Protozoal Myeloencephalitis (EPM)

• EPM is a disease that affects the central nervous system of horses and is caused by either the Sarcocystis neurona or Neospora hughesi – both of which are protozoan parasites.
• The disease presents with progressive and asymmetrical neurological deficits in affected horses. These signs can include incoordination, muscle atrophy, lameness, difficulty standing or walking, and other issues related to brain and spinal cord function.

Diagnosis of EPM

• The article notes that the diagnosis of EPM relies on assessing neurological symptoms, ruling out other neurological disorders, and the detection of antibodies linked to S. neurona or N. hughesi in the horse’s cerebrospinal fluid.

Treatment of EPM

• For the treatment of this disease, the researchers recommend the use of an FDA-approved anticoccidial drug. These types of drugs are typically used to treat diseases caused by a type of microscopic parasite called coccidia.
• Along with the use of pharmacological agents (specifically, anticoccidial drugs), the researchers also recommend providing medical and supportive treatment based on the severity of the horse’s neurological deficits and related complications.

EPM Prevention

• The article also focuses on providing insights into possible preventative measures based on recent data. However, the specifics of these preventative measures aren’t detailed in the abstract and may be covered in the full research paper.